The website of Personal Care Global

South African university develops rooibos phytosome nanotechnology

Researchers from Cape Peninsula University of Technology (CPUT) in South Africa are developing phytosome nanotechnology to boost the bioavailability of rooibos extracts in skincare formulations.

Up until now the bioavailability of rooibos (aka redbush) - the proportion of active ingredient that is absorbed by cells and that can have an effect when introduced into the body -  has been stymied by its high molecular weight.

”But, by loading Rooibos’ polyphenolic compounds (extracts) in a novel nano-delivery system will facilitate their penetration across the skin barriers, thereby enhancing their topical bioavailability,” said Dr Mariska Lilly, Senior Researcher of Proteomics & Molecular Biology at the Applied Microbial and Health Biotechnology Institute (AMHBI) at CPUT.

“Nanocarriers will not only help to protect the bioactive compounds in rooibos from oxidation and degradation, but can improve the solubility, absorption, long-term benefits, as well as their stability (shelf life),” she added.

Phytosomes as lipid-based nanocarriers play a crucial function in the enhancement of pharmacokinetic and pharmacodynamic properties of rooibos’ polyphenolic compounds and make nanotechnology a promising tool for the development of new topical formulations, said Lilly.

Previous studies have found rooibos has a protective effect against inflammation in skin cells.

“We knew that once the skin was exposed to the sun’s ultra-violet (UV) rays, rooibos extracts could remove precancerous damaged cells and block the onset of inflammation. It does so by hindering the multiplication of inflamed cells and ridding the body of them.

“Our studies went a step further. Instead of just studying one biomarker, we looked at several, and found the same to be true.”

Lilly added: “Rooibos indeed has a powerful anti-inflammatory effect, which protects the skin from the damaging effects of the sun, changing environmental conditions and pollution. However, the concentration of the rooibos extract must be just right.”

Before making the rooibos phytosome available to the market,  CPUT will conduct more research to determine the right concentration of rooibos and rate of bioavailability.

This will then be followed by clinical trials in humans where phytosome prototypes will be tested in small skin biopsies.

Upcoming Events

8th Anti-Ageing Skin Care Conference

Royal College of Physicians, London
29 - 30 November 2022

76th Annual Scientific Meeting & Showcase

JW Marriott LA Live, Los Angeles, California
12 - 14 December 2022

PCHi China 2023

The China Import and Export Fair Complex, Guangzhou
15-17 February 2023

in-cosmetics Global 2023 - Barcelona

Fira Barcelona Gran Via
28 - 30 March 2023

Access the latest issue of Personal Care Magazine on your mobile device together with an archive of back issues.

Download the FREE Personal Care Magazine app from your device's App store

Upcoming Events

8th Anti-Ageing Skin Care Conference

Royal College of Physicians, London
29 - 30 November 2022

76th Annual Scientific Meeting & Showcase

JW Marriott LA Live, Los Angeles, California
12 - 14 December 2022

PCHi China 2023

The China Import and Export Fair Complex, Guangzhou
15-17 February 2023

in-cosmetics Global 2023 - Barcelona

Fira Barcelona Gran Via
28 - 30 March 2023

Access the latest issue of Personal Care Magazine on your mobile device together with an archive of back issues.

Download the FREE Personal Care Magazine app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025